Abvc Biopharma Stock Price Prediction
| ABVC Stock | USD 0.52 0.03 5.45% |
Oversold Vs Overbought
38
Oversold | Overbought |
Wall Street Target Price 2.02 | Quarterly Revenue Growth 18.175 |
Using ABVC Biopharma hype-based prediction, you can estimate the value of ABVC Biopharma from the perspective of ABVC Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ABVC Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying ABVC because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ABVC Biopharma after-hype prediction price | USD 0.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ABVC |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ABVC Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ABVC Biopharma After-Hype Price Prediction Density Analysis
As far as predicting the price of ABVC Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ABVC Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ABVC Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ABVC Biopharma Estimiated After-Hype Price Volatility
In the context of predicting ABVC Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ABVC Biopharma's historical news coverage. ABVC Biopharma's after-hype downside and upside margins for the prediction period are 0.03 and 6.36, respectively. We have considered ABVC Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ABVC Biopharma is out of control at this time. Analysis and calculation of next after-hype price of ABVC Biopharma is based on 3 months time horizon.
ABVC Biopharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ABVC Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ABVC Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ABVC Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.28 | 5.84 | 0.01 | 0.01 | 2 Events / Month | 14 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.52 | 0.52 | 0.00 |
|
ABVC Biopharma Hype Timeline
ABVC Biopharma is presently traded for 0.52. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. ABVC is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.28%. %. The volatility of related hype on ABVC Biopharma is about 12643.3%, with the expected price after the next announcement by competition of 0.51. About 23.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. ABVC Biopharma recorded a loss per share of 0.77. The entity last dividend was issued on the 8th of May 2019. The firm had 1:10 split on the 25th of July 2023. Given the investment horizon of 90 days the next anticipated press release will be in a few days. Check out ABVC Biopharma Basic Forecasting Models to cross-verify your projections.ABVC Biopharma Related Hype Analysis
Having access to credible news sources related to ABVC Biopharma's direct competition is more important than ever and may enhance your ability to predict ABVC Biopharma's future price movements. Getting to know how ABVC Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ABVC Biopharma may potentially react to the hype associated with one of its peers.
ABVC Biopharma Additional Predictive Modules
Most predictive techniques to examine ABVC price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ABVC using various technical indicators. When you analyze ABVC charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ABVC Biopharma Predictive Indicators
The successful prediction of ABVC Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ABVC Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ABVC Biopharma based on analysis of ABVC Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ABVC Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ABVC Biopharma's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 19.53 | 10.65 | 10.28 | 9.76 | Receivables Turnover | 0.21 | 0.71 | 0.2 | 0.19 |
Story Coverage note for ABVC Biopharma
The number of cover stories for ABVC Biopharma depends on current market conditions and ABVC Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ABVC Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ABVC Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ABVC Biopharma Short Properties
ABVC Biopharma's future price predictability will typically decrease when ABVC Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ABVC Biopharma often depends not only on the future outlook of the potential ABVC Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ABVC Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.3 M | |
| Cash And Short Term Investments | 139.5 K |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |